Differential immunologic response to GnRHa alone vs. dual trigger for final follicular maturation: a proof-of-concept pilot study - Summary - MDSpire

Differential immunologic response to GnRHa alone vs. dual trigger for final follicular maturation: a proof-of-concept pilot study

  • By

  • Raoul Orvieto

  • Helly Vernitsky

  • Marina Safanaiev

  • Dolly Yuster

  • Dan Dominissini

  • July 10, 2026

  • 0 min

Share

Objective:

To explore the impact of GnRH agonist (GnRHa) vs. dual trigger (GnRHa plus hCG) for final follicular maturation on peripheral immune profiles in women undergoing oocyte cryopreservation.

Approach:
  • Study Design: Prospective proof-of-concept hypothesis-generating pilot study.
  • Setting: University-affiliated single center.
  • Participants: Five healthy women undergoing fertility preservation (n = 3 GnRHa trigger, n = 2 dual trigger).
  • Intervention: Ovarian stimulation with either GnRHa alone or dual trigger (GnRHa + hCG).
  • Immune Profiling: Performed at two time points: before trigger and on the day of oocyte retrieval.
Key Findings:
  • Dual trigger was associated with a trend toward lower CD4/CD8 T cell ratio.
  • An apparent increase in highly differentiated cytotoxic (CD57+) cell populations was observed.
  • No cases of ovarian hyperstimulation syndrome (OHSS) were reported; however, findings should not be interpreted as definitive.
Interpretation:

The addition of hCG to GnRHa trigger was associated with a shift toward a more cytotoxic lymphocyte profile post trigger; however, findings are exploratory and require validation in larger cohorts.

Limitations:
  • Small sample size limits the definitiveness of findings and introduces potential selection bias due to trigger allocation based on physician discretion.
Conclusion:

Findings require validation in larger, randomized cohorts to better understand their implications for reproductive outcomes and OHSS risk.

Original Source(s)

Related Content